PETS
PETMED EXPRESS INC
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.22
+1.67%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.23
From 52W high−68.72%
Volume15331.00
Market cap$26.45M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 4, 2026
Open
$1.23
From 52W high
−68.72%
Volume
15331.00
Market cap
$26.45M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
41.9
MomentumView details →
1D Return
+1.67%
YTD Return
−61.56%
SummaryUpdated Jun 1, 2026
PetMed Express, Inc. (NASDAQ:PETS) is a pet pharmacy company founded in 1996 and headquartered in Delray Beach, Florida. The company went public in 1999 and operates as one of the leading direct-to-consumer pet medication and health product retailers in the United States. Over its nearly three-decade history, PetMed Express has evolved from a traditional mail-order pharmacy to a multi-channel digital platform serving pet owners nationwide. The company has undergone significant transformation in recent years, including the acquisition and integration of PetCareRx, positioning itself as a comprehensive pet health and wellness provider beyond just prescription medications.
Similar companies
Latest newsMore news →
PetMed Express Inc. appointed Tamar Elkeles as a director effective September 17, 2026, with seats on the Compensation and Human Capital Committee and the Corporate Governance and Nominating Committee.44d agoPeter Batushansky became Chair of the Corporate Governance and Nominating Committee of PetMed Express Inc., effective September 28, 2026.48d agoPetMed Express Inc. elected Justin Mennen as Chair of the Board, effective September 28, 2026.48d ago